Cargando…
Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population()
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805797/ https://www.ncbi.nlm.nih.gov/pubmed/36599404 http://dx.doi.org/10.1016/j.jinf.2022.12.029 |
| _version_ | 1784862408699805696 |
|---|---|
| author | Camacho, Jorge Zulaica, Joao Giménez, Estela Rusu, Luciana Velandia-Álvarez, Sebastian Albert, Eliseo Peiró, Salvador Vanaclocha, Hermelinda Limón, Ramón Geller, Ron Navarro, David |
| author_facet | Camacho, Jorge Zulaica, Joao Giménez, Estela Rusu, Luciana Velandia-Álvarez, Sebastian Albert, Eliseo Peiró, Salvador Vanaclocha, Hermelinda Limón, Ramón Geller, Ron Navarro, David |
| author_sort | Camacho, Jorge |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9805797 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98057972023-01-04 Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population() Camacho, Jorge Zulaica, Joao Giménez, Estela Rusu, Luciana Velandia-Álvarez, Sebastian Albert, Eliseo Peiró, Salvador Vanaclocha, Hermelinda Limón, Ramón Geller, Ron Navarro, David J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2023-03 2023-01-01 /pmc/articles/PMC9805797/ /pubmed/36599404 http://dx.doi.org/10.1016/j.jinf.2022.12.029 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Camacho, Jorge Zulaica, Joao Giménez, Estela Rusu, Luciana Velandia-Álvarez, Sebastian Albert, Eliseo Peiró, Salvador Vanaclocha, Hermelinda Limón, Ramón Geller, Ron Navarro, David Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population() |
| title | Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population() |
| title_full | Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population() |
| title_fullStr | Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population() |
| title_full_unstemmed | Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population() |
| title_short | Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population() |
| title_sort | neutralizing antibodies against omicron ba.4/5 after covid-19 vaccination in sars-cov-2 experienced versus naïve individuals in the general population() |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805797/ https://www.ncbi.nlm.nih.gov/pubmed/36599404 http://dx.doi.org/10.1016/j.jinf.2022.12.029 |
| work_keys_str_mv | AT camachojorge neutralizingantibodiesagainstomicronba45aftercovid19vaccinationinsarscov2experiencedversusnaiveindividualsinthegeneralpopulation AT zulaicajoao neutralizingantibodiesagainstomicronba45aftercovid19vaccinationinsarscov2experiencedversusnaiveindividualsinthegeneralpopulation AT gimenezestela neutralizingantibodiesagainstomicronba45aftercovid19vaccinationinsarscov2experiencedversusnaiveindividualsinthegeneralpopulation AT rusuluciana neutralizingantibodiesagainstomicronba45aftercovid19vaccinationinsarscov2experiencedversusnaiveindividualsinthegeneralpopulation AT velandiaalvarezsebastian neutralizingantibodiesagainstomicronba45aftercovid19vaccinationinsarscov2experiencedversusnaiveindividualsinthegeneralpopulation AT alberteliseo neutralizingantibodiesagainstomicronba45aftercovid19vaccinationinsarscov2experiencedversusnaiveindividualsinthegeneralpopulation AT peirosalvador neutralizingantibodiesagainstomicronba45aftercovid19vaccinationinsarscov2experiencedversusnaiveindividualsinthegeneralpopulation AT vanaclochahermelinda neutralizingantibodiesagainstomicronba45aftercovid19vaccinationinsarscov2experiencedversusnaiveindividualsinthegeneralpopulation AT limonramon neutralizingantibodiesagainstomicronba45aftercovid19vaccinationinsarscov2experiencedversusnaiveindividualsinthegeneralpopulation AT gellerron neutralizingantibodiesagainstomicronba45aftercovid19vaccinationinsarscov2experiencedversusnaiveindividualsinthegeneralpopulation AT navarrodavid neutralizingantibodiesagainstomicronba45aftercovid19vaccinationinsarscov2experiencedversusnaiveindividualsinthegeneralpopulation AT neutralizingantibodiesagainstomicronba45aftercovid19vaccinationinsarscov2experiencedversusnaiveindividualsinthegeneralpopulation |